A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin

• Asıl Yazarlar: Peter Couroux (Yazar), Alexandre Brkovic (Yazar), Jason L. Vittitow (Yazar), Robert J. Israel (Yazar), Chinna Pamidi (Yazar), Jignesh Patel (Yazar), Maxime Barakat (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2022-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Ribavirin is an inosine monophosphate dehydrogenase inhibitor. Studies suggest ribavirin aerosol could be a safe and efficacious treatment option in the fight against coronaviruses. However, current treatment is long (12-18 h per day, 3-7 days), limiting clinical utility. A reduction in tre...